RO79525A - Procedeu de preparare a unui vaccin contra influentei gripei - Google Patents

Procedeu de preparare a unui vaccin contra influentei gripei

Info

Publication number
RO79525A
RO79525A RO80101109A RO10110980A RO79525A RO 79525 A RO79525 A RO 79525A RO 80101109 A RO80101109 A RO 80101109A RO 10110980 A RO10110980 A RO 10110980A RO 79525 A RO79525 A RO 79525A
Authority
RO
Romania
Prior art keywords
preparing
vaccine against
against influenza
influenza
vaccine
Prior art date
Application number
RO80101109A
Other languages
English (en)
French (fr)
Other versions
RO79525B (ro
Inventor
Karen Brown
Richard Stewart
Original Assignee
Cutter Laboratories Inc,Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RO79525(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories Inc,Us filed Critical Cutter Laboratories Inc,Us
Publication of RO79525A publication Critical patent/RO79525A/ro
Publication of RO79525B publication Critical patent/RO79525B/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
RO101109A 1979-05-15 1980-05-13 Procedeu de preparare a unui vaccin contra influentei RO79525B (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15

Publications (2)

Publication Number Publication Date
RO79525A true RO79525A (ro) 1984-07-17
RO79525B RO79525B (ro) 1984-09-30

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
RO101109A RO79525B (ro) 1979-05-15 1980-05-13 Procedeu de preparare a unui vaccin contra influentei

Country Status (13)

Country Link
EP (1) EP0019218B2 (ro)
JP (1) JPS55153723A (ro)
AR (1) AR220838A1 (ro)
AT (1) ATE16454T1 (ro)
AU (1) AU535804B2 (ro)
CA (1) CA1122527A (ro)
DE (1) DE3071225D1 (ro)
DK (1) DK154749C (ro)
ES (1) ES8104405A1 (ro)
IL (1) IL60063A0 (ro)
NO (1) NO801443L (ro)
RO (1) RO79525B (ro)
YU (1) YU41923B (ro)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
EP0791055B1 (en) * 1994-11-10 2012-01-25 Baxter Healthcare S.A. Method for producing biologicals in protein-free culture
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
JPH11509081A (ja) * 1994-11-16 1999-08-17 セント ジュード チルドレンズ リサーチ ホスピタル 新規の複製プロセス
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US6830917B2 (en) 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
CN101076355A (zh) 2004-11-03 2007-11-21 希龙公司 流感疫苗
WO2007132763A1 (ja) * 2006-05-11 2007-11-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute インフルエンザウイルスの増殖方法
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
CN102307590A (zh) 2009-02-10 2012-01-04 诺华有限公司 具有减少量的角鲨烯的流感疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (ro) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
EP0019218A3 (en) 1981-03-25
ES491517A0 (es) 1981-04-01
DK154749B (da) 1988-12-19
IL60063A0 (en) 1980-07-31
YU41923B (en) 1988-02-29
ATE16454T1 (de) 1985-11-15
DK212580A (da) 1980-11-16
DE3071225D1 (en) 1985-12-19
EP0019218B2 (de) 1995-03-01
EP0019218A2 (de) 1980-11-26
AR220838A1 (es) 1980-11-28
AU5824480A (en) 1980-11-20
JPS55153723A (en) 1980-11-29
RO79525B (ro) 1984-09-30
EP0019218B1 (de) 1985-11-13
JPH0124769B2 (ro) 1989-05-15
CA1122527A (en) 1982-04-27
ES8104405A1 (es) 1981-04-01
NO801443L (no) 1980-11-17
AU535804B2 (en) 1984-04-05
YU126580A (en) 1983-12-31
DK154749C (da) 1989-05-16

Similar Documents

Publication Publication Date Title
LU80084A1 (fr) Procede de preparation d'oligoimides
FI860015L (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
MY8500690A (en) N-alkylated aminoalcohols and salts thereof, a process for their preparation and pharmaceutical formulations containing them
FR2621785B1 (fr) Procede de preparation d'un roux
RO79525A (ro) Procedeu de preparare a unui vaccin contra influentei gripei
HU179290B (en) Process for preparing vaccine against poultry pest
PT87065A (pt) Process for the preparation of a vaccine against pasteurellosis
BE864265A (fr) Procede de preparation d'acides alcoyl-carboxyliques superieurs
LU80070A1 (fr) Procede de sechage par congelation pour la preparation de vaccin contre le meningocoque
PT69207A (en) Process for preparing pharmaceutical formulations
ZA791092B (en) Novel pentafluorobenzyloxycarbonyl derivatives,a process for their preparation and their use as insecticides and acaricides
LU80272A1 (fr) Procede de preparation d'agents therapeutiques antiallergiques
LU81064A1 (fr) Procede de preparation de trifluoromethylphenols
LU79503A1 (fr) Procede de preparation d'un vaccin syncytial du virus respiratoire
FR2322848A1 (fr) Procede de preparation d'un ester cyclopropane-carboxylique
BE877356R (fr) Procede de preparation de composes 1alpha-hydroxyles
PT67632A (en) Process for the preparation of a respiratory syncytial vaccine
PT71822A (en) Process for preparing vaccine for dental caries
PT83544A (fr) Procede de preparation d:un vaccin vivant contre la bronchocele
BE874713A (fr) Procede de preparation de p-amino-diphenylamine
PH14990A (en) Process for producing a vaccine
RO73104A (ro) Procedeu de preparare a unui vaccin contra oreionului
FR2329642A1 (fr) Procede de preparation d'un dihalogenovinyl-cyclo-propane-carboxylate
RO79572A2 (ro) Procedeu de preparare a unui vaccin gripal
LU79370A1 (fr) Procede de preparation d'acides furoyl-ou thenoylnaphtyloxyalkylcarboxyliques